Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Blood Cancer J. 2021 Oct 4;11(10):164. doi: 10.1038/s41408-021-00558-5.
Blood Cancer J. 2021.
PMID: 34608129
Free PMC article.
Clinical Trial.